Article Details

Immunotherapy post-surgery improves overall survival for kidney cancer - EurekAlert!

Retrieved on: 2024-04-17 22:08:06

Tags for this article:

Click the tags to see associated articles and topics

Immunotherapy post-surgery improves overall survival for kidney cancer - EurekAlert!. View article details on hiswai:

Summary

The article discusses how adjuvant therapy with pembrolizumab, an immunotherapy drug, improves overall survival in kidney cancer patients post-surgery, with research led by the Dana-Farber Cancer Institute and published in the NEJM.

Article found on: www.eurekalert.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up